for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Yabao Pharmaceutical Group Co Ltd

600351.SS

Latest Trade

6.16CNY

Change

-0.05(-0.81%)

Volume

4,925,832

Today's Range

6.16

 - 

6.24

52 Week Range

5.44

 - 

9.14

As of on the Shanghai Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
6.21
Open
6.22
Volume
4,925,832
3M AVG Volume
150.91
Today's High
6.24
Today's Low
6.16
52 Week High
9.14
52 Week Low
5.44
Shares Out (MIL)
770.00
Market Cap (MIL)
4,743.20
Forward P/E
--
Dividend (Yield %)
4.06

Latest Developments

More

Yabao Pharmaceutical Group sees FY 2018 H1 net profit up 35 pct to 40 pct

Yabao Pharmaceutical Group to pay cash dividend of 0.1 yuan per share on June 20

Yabao Pharmaceutical Group sees FY 2017 net profit to up 60 pct to 80 pct

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Yabao Pharmaceutical Group Co Ltd

YABAO PHARMACEUTICAL GROUP CO. LTD is a China-based company, principally engaged in the research and development, production and distribution of pharmaceuticals. The Company mainly provides light pastes, tablets, injections, capsules, oral liquids, bulk drugs and other pharmaceutical products. The Company is also engaged in the wholesaling and trading of pharmaceuticals. The Company distributes its products within domestic market and to overseas markets.

Industry

Biotechnology & Drugs

Contact Info

No.1

Gongye Boulevard

Fenglingdu Economic Development Zone

+86.10.57809936

http://www.yabao.com.cn

Executive Leadership

Wuxian Ren

Chairman of the Board, General Manager

Shaowei Bo

Vice Chairman of the Board

Zhefeng Zuo

Chief Financial Officer

Jun Liang

Deputy General Manager

Pengbo Ren

Deputy General Manager

Key Stats

Price To Earnings (TTM)
16.81
Price To Sales (TTM)
1.60
Price To Book (MRQ)
1.63
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
38.41
LT Debt To Equity (MRQ)
0.67
Return on Investment (TTM)
10.02
Return on Equity (TTM)
6.53

Latest News

BRIEF-Yabao Pharma Sees 2017 Net Profit Up 788-818 Pct On Rising Sales Of High Margin Products

* SAYS IT SEES 2017 NET PROFIT UP 788-818 PERCENT Y/Y FROM 225.2 MILLION YUAN ($34.44 million) YEAR AGO Source text in Chinese: http://bit.ly/2l7xYmF Further company coverage: ($1 = 6.5385 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)

BRIEF-Yabao Pharma's controlling shareholder plans exchangeable bonds issue

* Says controlling shareholder plans to raise up to 500 million yuan ($75.33 million) in exchangeable bonds issue

BRIEF-Yabao Pharmaceutical Group gets approval to conduct drug clinical trials for diabetes

* Says it gets an approval to conduct drug clinical trials of SY-008 which can be used for treatment of diabetes, from China Food and Drug Administration

BRIEF-Yabao Pharmaceutical Group says dividend payment date on June 30

* Says it will pay cash dividend of 0.02 yuan per share (before tax) for FY 2016 to shareholders of record on June 29

BRIEF-Yabao Pharmaceutical Group sees 2016 Q1~Q3 net profit to decrease by 50 pct to 70 pct

* sees 2016 Q1~Q3 net profit to decrease by 50 percent to 70 percent, compared to net profit of Q1~Q3 in 2015(206.7 million yuan)

BRIEF-Yabao Pharmaceutical Group appoints Grant Thornton as new auditor for 2016

Yabao Pharmaceutical Group : * Says it appoints Grant Thornton as new auditor for 2016 Source text in Chinese: https://goo.gl/yPJber Further company coverage: (Beijing Headline News)

BRIEF-Yabao Pharmaceutical Group to buy 75 pct stake in Shanghai Qingsong Pharmacy at 611.8 mln yuan

* Says it will buy 75 percent stake in Shanghai Qingsong Pharmacy Co Ltd at 611.8 million yuan

BRIEF-Yabao Pharma plans to acquire 75 pct stake in Qingsong Pharma for 611.8 mln yuan

* Says it plans to acquire 75 percent stake in Shanghai Qingsong Pharmaceutical Co Ltd for 611.8 million yuan ($91.71 million)

BRIEF-Yabao Pharmaceutical plans to set up unit in U.S.

Further company coverage: (Reporting by Hong Kong newsroom)

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up